BioWorld

March 24, 2010

Doing Well by Doing Good Can and Must Stem MDR-TB: WHO

€20M Equity Deal Gives Wilex Muscle for Partnering Talks

Stimuvax Cancer Trials on Hold Due to a Case of Encephalitis

Oncothyreon Inc. said that partner Merck Serono has halted clinical trials of Stimuvax after a study patient with multiple myeloma developed inflammation of the brain. (BioWorld Today) Read More

Positive U.S. Phase IIb Trial for GW's Sativex in Cancer Pain

Appointments And Advancements

Stock Movers

Other News To Note

Clinic Roundup

Today's news in brief

BioWorld

BioWorld briefs for June 9, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

BioWorld Science

Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.

Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors

BioWorld Science

Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...